keyword
https://read.qxmd.com/read/38798361/attrv-v30m-type-a-amyloid-fibrils-from-heart-and-nerves-exhibit-structural-homogeneity
#1
Binh An Nguyen, Shumaila Afrin, Anna Yakubovska, Virender Singh, Jaime Vaquer Alicea, Peter Kunach, Preeti Singh, Maja Pekala, Yasmin Ahmed, Maria Del Carmen Fernandez-Ramirez, Luis O Cabrera Hernandez, Rose Pedretti, Parker Bassett, Lanie Wang, Andrew Lemoff, Layla Villalon, Barbara Kluve-Beckerman, Lorena Saelices
ATTR amyloidosis is a systemic disease characterized by the deposition of amyloid fibrils made of transthyretin, a protein integral to transporting retinol and thyroid hormones. Transthyretin is primarily produced by the liver and circulates in blood as a tetramer. The retinal epithelium also secretes transthyretin, which is secreted to the vitreous humor of the eye. Because of mutations or aging, transthyretin can dissociate into amyloidogenic monomers triggering amyloid fibril formation. The deposition of transthyretin amyloid fibrils in the myocardium and peripheral nerves causes cardiomyopathies and neuropathies, respectively...
May 14, 2024: bioRxiv
https://read.qxmd.com/read/38796748/prolapsed-orbital-fat-to-the-infratemporal-fossa-via-enlarged-infraorbital-fissure-in-thyroid-eye-disease
#2
JOURNAL ARTICLE
Fernando Procianoy, Guilherme Ary Onsten, Marcelo Velloso Fabris, Juliano Adams Perez
No abstract text is available yet for this article.
May 26, 2024: Orbit
https://read.qxmd.com/read/38792551/synergistic-therapy-for-graves-ophthalmopathy-associated-eyelid-retraction-steroid-5-fu-and-botulinum-neurotoxin-a-combination
#3
JOURNAL ARTICLE
Yuri Kim, Helen Lew
Background: Graves' ophthalmopathy (GO) is characterized by upper eyelid retraction (UER), the most prevalent clinical sign. We aimed to assess the clinical efficacy of a multimodal combination of steroids, 5-fluorouracil (5-FU), and botulinum neurotoxin A (BoNT-A) injections in managing UER with GO and analyze the clinical factors in relation to the injection response. Methods: A total of 37 eyes from 23 patients were enrolled for UER with GO. At the endocrinology clinic, the patients were referred to the ophthalmology clinic after taking antithyroid medication for an average of 5...
May 20, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38778479/dynamic-risk-model-for-the-medical-treatment-of-graves-hyperthyroidism-according-to-treatment-duration
#4
JOURNAL ARTICLE
Meihua Jin, Chae A Kim, Min Ji Jeon, Won Bae Kim, Tae Yong Kim, Won Gu Kim
BACKGROUND: Changes in thyrotropin receptor antibody (TRAb) levels are associated with the clinical outcomes of Graves' hyperthyroidism. However, the effects of the patterns of TRAb changes on patient prognosis according to the treatment duration of antithyroid drugs (ATDs) are not well established. METHODS: In this retrospective cohort study, 1,235 patients with Graves' hyperthyroidism who were treated with ATDs for more than 12 months were included. Patients were divided into two groups according to treatment duration: group 1 (12-24 months) and group 2 (>24 months)...
May 23, 2024: Endocrinology and Metabolism
https://read.qxmd.com/read/38771880/cryo-em-structures-elucidate-the-multiligand-receptor-nature-of-megalin
#5
JOURNAL ARTICLE
Sawako Goto, Akihisa Tsutsumi, Yongchan Lee, Michihiro Hosojima, Hideyuki Kabasawa, Koichi Komochi, Satoru Nagatoishi, Kazuya Takemoto, Kouhei Tsumoto, Tomohiro Nishizawa, Masahide Kikkawa, Akihiko Saito
Megalin (low-density lipoprotein receptor-related protein 2) is a giant glycoprotein of about 600 kDa, mediating the endocytosis of more than 60 ligands, including those of proteins, peptides, and drug compounds [S. Goto, M. Hosojima, H. Kabasawa, A. Saito, Int. J. Biochem. Cell Biol. 157 , 106393 (2023)]. It is expressed predominantly in renal proximal tubule epithelial cells, as well as in the brain, lungs, eyes, inner ear, thyroid gland, and placenta. Megalin is also known to mediate the endocytosis of toxic compounds, particularly those that cause renal and hearing disorders [Y...
May 28, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38769210/salivary-lacrimal-and-nasal-salans-measure-to-assess-side-effects-following-radioactive-iodine-treatment-development-psychometric-properties-and-factor-structure
#6
JOURNAL ARTICLE
Jacqueline Jonklaas, Alaina L Carr, George Luta, Chenlu Yu, Roxanne E Jensen, Emma Reasner, Justin Winslow, Charlene C Kuo, Bruce J Davidson, Giuseppe Esposito, Gary Bloom, Samantha A Diamond-Rossi, Kristi D Graves
PURPOSE: This study aimed to develop and psychometrically evaluate a patient-reported outcome measure (PROM), SAlivary, LAcrimal, NaSal (SALANS), to document patients' symptoms after radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC). METHODS: We generated and iteratively revised SALANS items based on expert input, focus group discussions and feedback from cognitive testing (n = 17). We administered an initial SALANS measure with 39 items to patients diagnosed with DTC in the past two years (n = 105)...
May 20, 2024: Quality of Life Research
https://read.qxmd.com/read/38767537/assessment-of-choroidal-perfusion-indices-in-thyroid-eye-disease-by-using-optical-coherence-tomography
#7
JOURNAL ARTICLE
Ruchi Goel, Shalin Shah, Uddeshya Yadav
PURPOSE: To study choroidal vascularity changes in active and inactive TED orbits by using high-definition optical coherence tomography (HD-OCT) and correlate the changes with the duration and severity of TED and Barrets' index. METHODS: A cross-sectional study wherein 37 TED orbits and 30 healthy control (HC) orbits were enrolled. Choroid was imaged using HD-OCT scans centered at the fovea, and subfoveal choroidal thickness (SFCT) was measured. The OCT images were analyzed using ImageJ software to calculate choroidal vascularity index (CVI) and associated choroidal perfusion indices...
May 20, 2024: Indian Journal of Ophthalmology
https://read.qxmd.com/read/38765324/side-effects-and-adverse-events-after-treatment-with-teprotumumab-for-thyroid-eye-disease-a-retrospective-observational-case-series
#8
JOURNAL ARTICLE
Fabliha A Mukit, Andrew Manley, Akash B Patel, Marium Hashemi, Jacquelyn F Laplant, James C Fleming, Brian T Fowler
As the use of teprotumumab for thyroid eye disease (TED) becomes more prolific, there remains a scarcity of literature regarding the associated side effects and adverse events of teprotumumab use. The authors present a single-center retrospective, observational case review of TED patients who received at least a single dose of teprotumumab infusion at the oculofacial plastic surgery service between February 2020 and July 2023. The most predominant recollected side effects were fatigue, brittle nails, dry eye symptoms, hair loss, muscle spasms, and dry mouth...
April 2024: Curēus
https://read.qxmd.com/read/38763497/an-evidence-based-approach-to-diagnosing-patients-presenting-with-orbital-inflammatory-syndromes-an-american-ophthalmological-society-thesis
#9
JOURNAL ARTICLE
Michael K Yoon, Jonathan E Lu
PURPOSE: The initial management of patients presenting with orbital inflammatory syndromes (OIS) varies - with some pursuing a diagnostic workup while others treat without any testing. The evidence behind this rationale is limited. A review of patients with orbital inflammation is performed with analysis of diagnostic testing to develop a workflow for such patients. DESIGN: A retrospective review of patients presenting with acute orbital inflammation at a single institution from 2011 - 2020 was conducted...
May 17, 2024: American Journal of Ophthalmology
https://read.qxmd.com/read/38762243/tear-biomarkers
#10
REVIEW
Erika Ponzini
An extensive exploration of lacrimal fluid molecular biomarkers in understanding and diagnosing a spectrum of ocular and systemic diseases is presented. The chapter provides an overview of lacrimal fluid composition, elucidating the roles of proteins, lipids, metabolites, and nucleic acids within the tear film. Pooled versus single-tear analysis is discussed to underline the benefits and challenges associated with both approaches, offering insights into optimal strategies for tear sample analysis. Subsequently, an in-depth analysis of tear collection methods is presented, with a focus on Schirmer's test strips and microcapillary tubes methods...
2024: Advances in Clinical Chemistry
https://read.qxmd.com/read/38760615/an-observational-study-on-the-safety-of-teprotumumab-based-on-faers-database
#11
JOURNAL ARTICLE
Xing-Long Wang, Shan-Shan Xu, Jian-Bo Zhou, Zhi-Hui Song
OBJECTIVE: Teprotumumab plays an important role in thyroid eye disease pathogenesis and progression. We intend to mine the adverse event (AE) signals from a relevant database, thereby contributing to the safe use of teprotumumab. METHODS: The data obtained from the ASCII data packages in the FAERS database from January 2020 to the second quarter of 2023 were imported into the SAS software (version 9.4) for data cleaning and analysis. Disproportionality analysis was performed using the reporting odds ratio (ROR) in conjunction with the United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA) omnibus standard method to detect positive signals...
May 17, 2024: Endocrine
https://read.qxmd.com/read/38755728/risk-factors-of-primary-sj%C3%A3-gren-s-syndrome-combined-with-osteoporosis
#12
REVIEW
Wuxinrui Huang, Jing Tian, Jieyu He
Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease that is prevalent in middle-aged and elderly women, characterized by dry mouth, dry eyes, fatigue, and joint pain. Nearly one-third pSS patients have been suffering with osteoporosis (OP), displaying symptoms of lumbago, back pain, and even fracture, all of which severely affect their life quality. Common risk factors for pSS and OP include gender and age, persistent state of inflammation, immune disorders, intestinal flora imbalance, vitamin D deficiency, dyslipidemia and sarcopenia...
February 28, 2024: Zhong Nan da Xue Xue Bao. Yi Xue Ban, Journal of Central South University. Medical Sciences
https://read.qxmd.com/read/38752390/papp-a-as-a-potential-target-in-thyroid-eye-disease
#13
JOURNAL ARTICLE
Cheryl A Conover, Laurie K Bale, Marius N Stan
CONTEXT: Proptosis in Thyroid Eye Disease (TED) can result in facial disfigurement and visual dysfunction. Treatment with Insulin-like growth factor I receptor (IGF-IR) inhibitors has been shown to be effective in reducing proptosis but with side effects. OBJECTIVE: To test the hypothesis that inhibition of IGF-IR indirectly and more selectively with PAPP-A inhibitors attenuates IGF-IR signaling in TED. DESIGN: Informed consent was obtained from TED patients undergoing surgery, and retro-orbital tissue collected for fibroblast isolation and culture...
May 16, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38751133/triamcinolone-injection-in-the-treatment-of-lid-retraction-for-thyroid-associated-ophthalmopathy-a-systematic-review
#14
REVIEW
Rona Ali Badjrai, Lourisa Ruth Eldinia, Lazuardiah Anandi, Fierda Ovita Azhari, Erika Anggraini, Brigitta Marcia Budihardja, Syntia Nusanti
INTRODUCTION AND OBJECTIVES: Lid retraction is one of the most common symptoms of Thyroid-Associated Ophthalmopathy (TAO), which potentially precipitates various complications, such as dry eyes, exposure keratopathy, and cosmetic concerns. Local corticosteroid injections, such as triamcinolone, have been proposed as a choice of treatment for TAO. This approach may be a favorable alternative for patients intolerant to the systemic effects of high-dose methylprednisolone. However, the efficacy of this intervention remains unestablished...
May 15, 2024: European Journal of Ophthalmology
https://read.qxmd.com/read/38746201/a-novel-association-between-human-papillomavirus-and-thyroid-eye-disease
#15
Ishita Garg, Benjamin I Meyer, Ryan A Gallo, Sara T Wester, Daniel Pelaez
CONTEXT: Thyroid eye disease (TED) is an autoimmune disease characterized by orbital inflammation and tissue remodeling. TED pathogenesis is poorly understood but is linked to autoantibodies to thyroid-stimulating hormone receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R). OBJECTIVE: To explore the potential involvement of viral infections in TED pathogenesis. METHODS: Using NCBI BLAST, we compared human TSHR and IGF-1R proteins to various viral proteomes, including Papillomaviridae , Paramyxoviridae , Herpesviridae , Enterovirus , Polyomaviridae , and Rhabdoviridae ...
April 30, 2024: medRxiv
https://read.qxmd.com/read/38745352/localized-retrobulbar-hematoma-and-optic-disc-edema-with-corresponding-visual-field-defect-after-uneventful-strabismus-surgery-in-a-patient-with-thyroid-associated-orbitopathy-a-case-report
#16
JOURNAL ARTICLE
Sheng-Chi Yang, Chia-Chen Lin, Chun-Chieh Lai
No abstract text is available yet for this article.
May 15, 2024: Journal of Neuro-ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society
https://read.qxmd.com/read/38734625/potential-role-of-igf-1r-in-the-interaction-between-orbital-fibroblasts-and-b-lymphocytes-an-implication-for-b-lymphocyte-depletion-in-the-active-inflammatory-phase-of-thyroid-associated-ophthalmopathy
#17
JOURNAL ARTICLE
Renyan Wang, Delu Song, Yong Zhong, Hui Li
BACKGROUND: Thyroid eye disease (TED) is an inflammatory process involving lymphocyte-mediated immune response and orbital tissue damage. The anti-insulin-like growth factor-1 receptor (IGF-1R) antibodies produced by B lymphocytes are involved in the activation of orbital fibroblasts and the inflammatory process of orbital tissue damage in TED. The purpose of this study was to explore the role of IGF-1R in the mechanistic connection between orbital fibroblasts and B lymphocytes in TED...
May 11, 2024: BMC Immunology
https://read.qxmd.com/read/38729283/cyclosporin-a-inhibits-pdgf-bb-induced-hyaluronan-synthesis-in-orbital-fibroblasts
#18
JOURNAL ARTICLE
Erika Galgoczi, Zsanett Molnar, Monika Katko, Bernadett Ujhelyi, Zita Steiber, Endre V Nagy
Orbital connective tissue changes are contributors to the pathogenesis in thyroid eye disease (TED). Activated fibroblasts respond to immune stimuli with proliferation and increased hyaluronan (HA) production. Cyclosporin A (CsA) was reported to be beneficial in the treatment of TED. PDGF isoforms are increased in orbital tissue of TED patients and enhance HA production. We aimed to study the effect of CsA on HA production and hyaluronan synthase (HAS1, 2 and 3) and hyaluronidase (HYAL1 and 2) mRNA expressions in orbital fibroblasts (OFs)...
May 8, 2024: Chemico-biological Interactions
https://read.qxmd.com/read/38723892/novel-measures-of-quality-of-life-for-patients-with-thyroid-eye-disease
#19
JOURNAL ARTICLE
Linus Amarikwa, Anupam Kotwal
No abstract text is available yet for this article.
May 8, 2024: Endocrine Practice
https://read.qxmd.com/read/38722772/effects-of-teprotumumab-on-eyelid-retraction-in-thyroid-eye-disease
#20
JOURNAL ARTICLE
Eman M Al-Sharif, Jason Zhou, Marissa K Shoji, Kaela Acuff, Catherine Y Liu, Bobby S Korn, Don O Kikkawa
PURPOSE: This study evaluates the efficacy of teprotumumab in reducing eyelid retraction in thyroid eye disease (TED) patients. METHODS: This retrospective study included patients with active or chronic moderate-to-severe TED who completed at least 4 cycles of teprotumumab. Patients with upper and/or lower eyelid retraction, defined as margin-to-reflex distance (MRD) 1 and/or MRD2 of more than 5 mm, in one or OU were included. The main outcome measure was a change in MRD1 and MRD2 after treatment...
May 9, 2024: Ophthalmic Plastic and Reconstructive Surgery
keyword
keyword
33778
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.